Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879018 | PMC |
http://dx.doi.org/10.1007/s40477-016-0196-3 | DOI Listing |
Diagnostics (Basel)
August 2024
Department of Radiology, General University of Patras, 61000 Patras, Greece.
Urol Int
December 2024
Department of Urology, Misugikai Otokoyama Hospital, Kyoto, Japan.
Gan To Kagaku Ryoho
December 2023
Dept. of Hematology, Osaka General Hospital of West Japan Railway Company.
Cureus
June 2023
Pathology, Advocate Lutheran General Hospital, Park Ridge, USA.
Plasma cell neoplasms include various conditions ranging from indolent conditions such as monoclonal gammopathy of undetermined significance (MGUS) to more aggressive forms such as multiple myeloma (MM). The World Health Organization classifies plasmacytomas into two types: solitary osseous plasmacytoma (SOP) and extramedullary plasmacytoma (EMP). Most primary EMPs occur in the upper gastrointestinal tract, head and neck, upper respiratory system, central nervous system, lungs, liver, spleen, and kidneys.
View Article and Find Full Text PDFCancer Diagn Progn
September 2022
Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, U.S.A.
Background/aim: Extramedullary plasmacytoma (EMP) is defined as a localized plasma cell neoplasm that arises in tissues other than the bone. The most common sites of involvement of EMP are the upper airways followed by lymph nodes, gastrointestinal tract, thyroid gland, skin, brain, liver, and lungs. Testicular plasmacytoma has a very rare occurrence with about 70 cases reported in literature to date.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!